Cypher SES
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cypher SES, covering 2008-04-30 to 2008-04-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions. [Phase 4]